Are you Dr. Kaubisch?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 109 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
MMC Dept of Oncology
111 East 210TH Street
Bronx, NY 10467Phone+1 718-920-4057Fax+1 718-798-7474
Summary
- Dr. Andreas Kaubisch, MD is an oncologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with Montefiore Medical Center, St. Barnabas Hospital, and Burke Rehabilitation Hospital.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1992 - 1995
Columbia University Vagelos College of Physicians and SurgeonsClass of 1992
Certifications & Licensure
NY State Medical License 1994 - 2025
Clinical Trials
- Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer Start of enrollment: 2002 Mar 01
- A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer Start of enrollment: 2003 Jun 01
- Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 42 citationsWho Benefits From Adjuvant Radiation Therapy for Gastric Cancer? A Meta-AnalysisNitin Ohri, Madhur Garg, Santiago Aparo, Andreas Kaubisch, Wolfgang A. Tomé
International Journal of Radiation Oncology, Biology, Physics. 2013-06-01 - 108 citationsPregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.Hongwei Wang, Madhukumar Venkatesh, Hao Li, Regina Goetz, Subhajit Mukherjee
The Journal of Clinical Investigation. 2011-08-01 - 5 citationsCenters with more therapeutic modalities are associated with improved outcomes for patients with hepatocellular carcinoma.Julie M. Jiang, Nitin Ohri, Justin Tang, Renee M. Moadel, Jacob Cynamon
Journal of Gastrointestinal Oncology. 2019-02-20
Professional Memberships
- Member
